HB 1984
Pub
Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
- Tennessee
- House / Assembly
- Introduced Jan 22, 2026
- Session 114
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Tennessee’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
31 actions-
Pub. Ch. 753
-
Effective date(s) 04/16/2026
-
Signed by Governor.
-
Transmitted to Governor for his action.
-
Signed by H. Speaker
-
Signed by Senate Speaker
-
Enrolled; ready for sig. of H. Speaker.
-
Passed H., Ayes 82, Nays 1, PNV 10
-
Engrossed; ready for transmission to Sen.
-
Sponsor(s) Added.
-
Received from House, Passed on First Consideration
-
Senate substituted House Bill for companion Senate Bill.
-
Passed Senate, Ayes 28, Nays 3
-
H. Placed on Consent Calendar for 3/30/2026
-
Placed on cal. Calendar & Rules Committee for 3/26/2026
-
Rec. for pass; ref to Calendar & Rules Committee
-
Placed on cal. Health Committee for 3/17/2026
-
No Action Taken
-
Placed on cal. Health Committee for 3/10/2026
-
Action def. in Health Committee to 3/10/2026
-
Sponsor(s) Added.
-
Placed on cal. Health Committee for 3/3/2026
-
Rec. for pass by s/c ref. to Health Committee
-
Sponsor(s) Added.
-
Sponsor change.
-
Sponsor(s) withdrawn.
-
Placed on s/c cal Health Subcommittee for 2/18/2026
-
P2C, ref. to Health Committee
-
Assigned to s/c Health Subcommittee
-
Intro., P1C.
-
Filed for introduction